Immunic, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $15.5M | $35.7M | $46.7M | $106.7M | $86.9M | $127.5M | $29.4M | $13.1M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $22.9M | $39.3M | $52.5M | $125.9M | $105.0M | $133.7M | $32.2M | $13.3M |
| Property, Plant & Equipment | $608.0K | $545.0K | $466.0K | $294.0K | $152.0K | $203.0K | $80.0K | $40.0K |
| Goodwill | — | — | — | $0 | $33.0M | $33.0M | $33.0M | $0 |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $24.1M | $40.9M | $54.3M | $127.8M | $139.1M | $167.9M | $66.0M | $13.4M |
| Liabilities | ||||||||
| Accounts Payable | $10.1M | $7.8M | $5.1M | $4.3M | $3.7M | $3.7M | $2.4M | $1.4M |
| Total Current Liabilities | $30.6M | $22.2M | $24.7M | $13.1M | $11.4M | $8.4M | $7.1M | $1.9M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $30.7M | $22.4M | $25.4M | $14.1M | $12.0M | $9.1M | $7.6M | $1.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-608.6M | $-511.4M | $-410.9M | $-317.3M | $-196.9M | $-103.9M | $-59.9M | $-25.0M |
| Total Stockholders' Equity | $-6.7M | $18.4M | $28.9M | $113.7M | $127.1M | $158.8M | $58.4M | $-25.7M |